Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Jetema USA Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06246552
- Locations
- 🇺🇸
Ablon Skin Institute & Research Center, Manhattan Beach, California, United States
News
No news found